Biogen Idec has appointed Michael Lytton as its new executive vice president of business and corporate development.
CryoPort Systems announced that Larry G. Stambaugh has been elected by the board of directors to become the president and CEO of CryoPort, in addition to his current position as chairman of the board. The current CEO Peter Berry handed over his role of president and CEO of CryoPort effective immediately and has been engaged by the company as an advisor to the CEO. He will also remain on the board of directors.
Poniard Pharmaceuticals has appointed Greg Weaver CFO and senior vice president.
Sopherion Therapeutics named Dr. Marcel Rozencweig as senior executive vice president for clinical affairs.
Axial Biotech announced that Roberto A. Macina, Ph.D., has joined the executive management team as the company's new vice president of research and development.
Flamel Technologies has appointed Jeffery Vick as its new chief business officer.
MorphoSys has named Dr. Ulrich Moebius as its new head of pre-clinical development and project management.
Novacta Therapeutics named David Pompliano to the board of directors. In addition to his role of non-executive director Dr. Pompliano will also provide strategic direction to Novacta's R&D team and will hold the position of chairman of the Scientific Advisory Board.
Optimer Pharmaceuticals said it appointed Francois-Xavier Frapaise as senior vice president and chief scientific officer and Peter Grebow to the company's board of directors.
Micromet announced that Dr. Kapil Dhingra has joined its board of directors.
Covance has appointed Bradley Sheares to its board of directors.
Cytokinetics has appointed Dr. John T. Henderson to the company's board of directors.
Eli Lilly has elected Ralph Alvarez , the president and chief operating officer of McDonald's, to its board of directors.
VaxInnate Corporation announced that David J. Williams, retired chairman and chief executive officer of Sanofi Pasteur, has joined the company's board of directors.